Amniotics AB (publ) (AMNI.ST)

SEK 0.01

(5.88%)

Eps Summary of Amniotics AB (publ)

  • Amniotics AB (publ)'s latest annual eps in 2023 was -0.01 SEK , up 96.33% from previous year.
  • Amniotics AB (publ)'s latest quarterly eps in 2023 FY was N/A , up 77.47% from previous quarter.
  • Amniotics AB (publ) reported an annual eps of -0.30 SEK in 2022, up 9.09% from previous year.
  • Amniotics AB (publ) reported an annual eps of -0.33 SEK in 2021, down -94.12% from previous year.
  • Amniotics AB (publ) reported a quarterly eps of -0.00 SEK for 2023 Q4, up 96.67% from previous quarter.
  • Amniotics AB (publ) reported a quarterly eps of -0.13 SEK for 2023 Q1, down -101.86% from previous quarter.

Annual Eps Chart of Amniotics AB (publ) (2023 - 2018)

Historical Annual Eps of Amniotics AB (publ) (2023 - 2018)

Year Eps Eps Growth
2023 -0.01 SEK 96.33%
2022 -0.30 SEK 9.09%
2021 -0.33 SEK -94.12%
2020 -0.17 SEK -199.3%
2019 -0.06 SEK -52.28%
2018 -0.04 SEK 0.0%

Peer Eps Comparison of Amniotics AB (publ)

Name Eps Eps Difference
Alligator Bioscience AB (publ) -0.55 SEK 98.0%
Ziccum AB (publ) -1.54 SEK 99.286%
Modus Therapeutics Holding AB (publ) -1.01 SEK 98.911%
BioArctic AB (publ) 2.60 SEK 100.423%
Sprint Bioscience AB (publ) -0.01 SEK -74.603%
Mendus AB (publ) -4.40 SEK 99.75%
Genovis AB (publ.) 0.94 SEK 101.17%
Intervacc AB (publ) -1.69 SEK 99.349%
QuiaPEG Pharmaceuticals Holding AB (publ) -0.22 SEK 95.0%
Active Biotech AB (publ) -0.17 SEK 93.529%
Magle Chemoswed Holding AB (publ) 1.13 SEK 100.973%
Bio-Works Technologies AB (publ) -1.57 SEK 99.299%
Aptahem AB (publ) -0.05 SEK 77.226%
Vicore Pharma Holding AB (publ) -3.22 SEK 99.658%
Kancera AB (publ) -0.80 SEK 98.625%
Infant Bacterial Therapeutics AB (publ) -9.95 SEK 99.889%
Fluicell AB (publ) -0.24 SEK 95.417%
Saniona AB (publ) -1.29 SEK 99.147%
Lipigon Pharmaceuticals AB (publ) -0.19 SEK 94.211%
Biovica International AB (publ) -2.14 SEK 99.486%
Spago Nanomedical AB (publ) -0.43 SEK 97.442%
AcouSort AB (publ) -1.29 SEK 99.147%
Xintela AB (publ) -0.13 SEK 91.538%
Abliva AB (publ) -0.09 SEK 87.832%
Egetis Therapeutics AB (publ) -1.27 SEK 99.134%
Karolinska Development AB (publ) 0.02 SEK 155.0%
OncoZenge AB (publ) -1.36 SEK 99.191%
2cureX AB (publ) -1.85 SEK 99.405%
CombiGene AB (publ) -1.80 SEK 99.389%
Asarina Pharma AB (publ) -0.57 SEK 98.07%
Calliditas Therapeutics AB (publ) -8.69 SEK 99.873%
Camurus AB (publ) 7.78 SEK 100.141%
Corline Biomedical AB -0.08 SEK 86.936%
IRLAB Therapeutics AB (publ) -3.43 SEK 99.679%
Isofol Medical AB (publ) -0.23 SEK 95.217%
I-Tech AB 1.70 SEK 100.647%
Hansa Biopharma AB (publ) -15.83 SEK 99.931%
Cyxone AB (publ) -0.22 SEK 95.0%
ExpreS2ion Biotech Holding AB (publ) -1.98 SEK 99.444%
Biosergen AB -0.60 SEK 98.167%
Cantargia AB (publ) -1.65 SEK 99.333%
NextCell Pharma AB -1.03 SEK 98.932%
Xspray Pharma AB (publ) -6.76 SEK 99.837%
Elicera Therapeutics AB (publ) -0.83 SEK 98.675%
Nanologica AB (publ) -2.05 SEK 99.463%
SynAct Pharma AB -6.64 SEK 99.834%
Annexin Pharmaceuticals AB (publ) -0.26 SEK 95.769%
Stayble Therapeutics AB (publ) -0.92 SEK 98.804%
LIDDS AB (publ) -0.63 SEK 98.254%
Lipum AB (publ) -4.45 SEK 99.753%
BioInvent International AB (publ) -5.02 SEK 99.781%
Alzinova AB (publ) -0.41 SEK 97.317%
Oncopeptides AB (publ) -1.96 SEK 99.439%
Pila Pharma AB (publ) -0.47 SEK 97.66%
Guard Therapeutics International AB (publ) -11.26 SEK 99.902%
Scandinavian ChemoTech AB (publ) -1.13 SEK 99.027%
Simris Alg AB (publ) -0.16 SEK 93.125%
Diamyd Medical AB (publ) -1.60 SEK 99.313%
Xbrane Biopharma AB (publ) -1.27 SEK 99.134%
Ascelia Pharma AB (publ) -3.24 SEK 99.66%
Diagonal Bio AB (publ) -0.32 SEK 96.563%